Expression Levels of GABA-A Receptor Subunit Alpha 3, Gabra3 and Lipoprotein Lipase, Lpl Are Associated with the Susceptibility to Acetaminophen-Induced Hepatotoxicity.
10.4062/biomolther.2016.076
- Author:
Minjeong KIM
1
;
Jun Won YUN
;
Kyeho SHIN
;
Yejin CHO
;
Mijeong YANG
;
Ki Taek NAM
;
Kyung Min LIM
Author Information
1. College of Pharmacy, Ewha Womans University, Seoul 03760, Republic of Korea. kmlim@ewha.ac.kr
- Publication Type:Original Article
- Keywords:
Acetaminophen;
Hepatotoxicity;
Toxicogenomics;
GABA-A receptor subunit alpha 3;
Lipoprotein lipase
- MeSH:
Acetaminophen;
Animals;
Drug-Induced Liver Injury;
Genetic Variation;
Incidence;
Lipoprotein Lipase*;
Lipoproteins*;
Liver;
Methods;
Mice;
Microarray Analysis;
Real-Time Polymerase Chain Reaction;
Receptors, GABA-A*;
Toxicogenetics;
Transcriptome
- From:Biomolecules & Therapeutics
2017;25(2):112-121
- CountryRepublic of Korea
- Language:English
-
Abstract:
Drug-induced liver injury (DILI) is the serious and fatal drug-associated adverse effect, but its incidence is very low and individual variation in severity is substantial. Acetaminophen (APAP)-induced liver injury accounts for >50% of reported DILI cases but little is known for the cause of individual variations in the severity. Intrinsic genetic variation is considered a key element but the identity of the genes was not well-established. Here, pre-biopsy method and microarray technique was applied to uncover the key genes for APAP-induced liver injury in mice, and a cause and effect experiment employing quantitative real-time PCR was conducted to confirm the correlation between the uncovered genes and APAP-induced hepatotoxicity. We identified the innately and differentially expressed genes of mice susceptible to APAP-induced hepatotoxicity in the pre-biopsied liver tissue before APAP treatment through microarray analysis of the global gene expression profiles (Affymetrix GeneChip® Mouse Gene 1.0 ST for 28,853 genes). Expression of 16 genes including Gdap10, Lpl, Gabra3 and Ccrn4l were significantly different (t-test: FDR <10%) more than 1.5 fold in the susceptible animals than resistant. To confirm the association with the susceptibility to APAP-induced hepatotoxicity, another set of animals were measured for the expression level of selected 4 genes (higher two and lower two genes) in the liver pre-biopsy and their sensitivity to APAP-induced hepatotoxicity was evaluated by post hoc. Notably, the expressions of Gabra3 and Lpl were significantly correlated with the severity of liver injury (p<0.05) demonstrating that these genes may be linked to the susceptibility to APAP-induced hepatotoxicity.
